Global Chemotherapy induced neutropenia Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431861
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Amgen
  • Apotex
  • Baxter International
  • Biogenomics Limited
  • Ligand Pharmaceuticals
  • Lupin Limited
  • MORE
Chemotherapy induced neutropenia Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Chemotherapy induced neutropenia market was valued at US$ 7.71 Bn in 2016, and is expected to reach US$ 12.56 Bn by 2025, expanding at a CAGR of 5.6% from 2017 to 2025.

Market Insights

Global chemotherapy induced neutropenia market will show significant growth during forecast period due to some factors such as rising incidence of different forms of cancer, extensive R&D activities in development of novel therapeutics and upsurge funding by the government for life threatening disease in developed countries would drive the market growth during forecast period. For the purpose of study market is segmented on the basis of treatment type (antibiotic therapy, colony-stimulating factor therapy, granulocyte transfusion and splenectomy procedure) and geography. It is studied that currently, colony-stimulating factor therapy is preferably used in market because colony-stimulating factor such as granulocyte-CSF (G-CSF) and granulocyte-macrophage CSF (GM-CSF) have ability to stimulate and accelerate the production of one or more cell lines in the bone marrow, furthermore regulatory guidelines recommend prophylactic G-CSF treatment for chemotherapy patients with an overall high risk (=20%) is driving the growth of G-CSF market globally. In the base year 2016, North America held largest share in global chemotherapy induced neutropenia market, United States held largest market share in North America due to factors such as upsurge funding by government and increase in incidence of different forms of cancer. It is estimated that Asia Pacific will show highest growth during forecast period due to increasing healthcare awareness and increasing prevalence of different forms of cancer would fuel market growth.

Market Competition Assessment

The Chemotherapy induced neutropenia market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Amgen, Apotex, Baxter International, Biogenomics Limited, Ligand Pharmaceuticals, Lupin Limited, Novartis AG, Pfizer Inc., Reddy’s Laboratory, Sanofi, Teva Pharmaceuticals Industries and other.

Key Market Movements:
  • Factors such as rising incidence of different forms of cancer, extensive research and development activities and upsurge funding by the government for treatment are expected to drive the growth of chemotherapy induced neutropenia market during forecast period.
  • However, some factors such as lower healthcare awareness in some developing countries, lack of medication availability in most poor income countries may negatively impacting the growth of chemotherapy induced neutropenia market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen
  • Apotex
  • Baxter International
  • Biogenomics Limited
  • Ligand Pharmaceuticals
  • Lupin Limited
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Chemotherapy Induced Neutropenia Market Snapshot
2.2 Global Chemotherapy Induced Neutropenia Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Chemotherapy Induced Neutropenia Market Share, by Geography, 2016 (Value %)

Chapter 3 Chemotherapy Induced Neutropenia Market Analysis
3.1 Global Chemotherapy Induced Neutropenia Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Chemotherapy Induced Neutropenia Market

Chapter 4 Global Chemotherapy Induced Neutropenia Market, by Treatment Type
4.1 Overview
4.2 Top 3 Countries
4.3 Antibiotic Therapy
4.4 Colony Stimulating Factor Therapy
4.5 Granulocyte Transfusion
4.6 Splenectomy Procedure

Chapter 5 Global Chemotherapy Induced Neutropenia Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America (Brazil, Mexico, Rest of Latin America)
5.6 Middle East and Africa (GCC, Rest of MEA)

Chapter 6 Company Profiles
6.1 Amgen
6.2 Apotex
6.3 Baxter International
6.4 Biogenomics Limited
6.5 Ligand Pharmaceuticals
6.6 Lupin Limited
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Reddy’s Laboratory
6.10 Sanofi
6.11 Teva Pharmaceuticals Industries

List of Figures
Fig. 1 Chemotherapy Induced Neutropenia Market: Research Methodology
Fig. 2 Global Chemotherapy Induced Neutropenia Market, by Treatmnet Type, 2016 (US$ Bn)
Fig. 3 Global Chemotherapy Induced Neutropenia Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Chemotherapy Induced Neutropenia Market, by Geography, 2016
Fig. 5 Antibiotic Therapy Market for Chemotherapy Induced Neutropenia, 2015 - 2025 (US$ Bn)
Fig. 6 Colony Stimulating Factor Therapy Market for Chemotherapy Induced Neutropenia, 2015 - 2025 (US$ Bn)
Fig. 7 Granulocyte Transfusion for Chemotherapy Induced Neutropenia, 2015 - 2025 (US$ Bn)
Fig. 8 Splenectomy Procedure Market for Chemotherapy Induced Neutropenia, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Chemotherapy Induced Neutropenia Market
Table 2 Global Chemotherapy Induced Neutropenia Market, by Treatment Type, 2015 - 2025 (US$ Bn)
Table 3 Global Chemotherapy Induced Neutropenia Market, by Top 3 Countries, 2015 - 2025 (US$ Bn)
Table 4 Global Chemotherapy Induced Neutropenia Market, by Geography, 2015 - 2025 (US$ Bn)
Table 5 North America Chemotherapy Induced Neutropenia Market, by Country, 2015 - 2025 (US$ Bn)
Table 6 Europe Chemotherapy Induced Neutropenia Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Asia Pacific Chemotherapy Induced Neutropenia Market, by Country, 2015 - 2025 (US$ Bn)
Table 8 Latin America Chemotherapy Induced Neutropenia Market, by Country, 2015 - 2025 (US$ Bn)
Table 9 Middle East and Africa Chemotherapy Induced Neutropenia Market, by Country, 2015 - 2025 (US$ Bn)
Table 10 Amgen: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Apotex: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Baxter International: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Biogenomics Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Ligand Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Lupin Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Reddy’s Laboratory: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Sanofi: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 20 Teva Pharmaceuticals Industries: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Amgen
  • Apotex
  • Baxter International
  • Biogenomics Limited
  • Ligand Pharmaceuticals
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc.
  • Reddy’s Laboratory
  • Sanofi
  • Teva Pharmaceuticals Industries
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll